Zhenyuan Tablet is an unilateral preparation extracted from ginseng fruit, the active ingredient is total saponin, which is mainly used for the treatment of coronary heart disease, menopausal syndrome, neurasthenia, recessive diabetes, etc. It belongs to national medical insurance products which is a specialist medicine for coronary heart disease and diabetes in China. It has been recognized by experts and patients since its listing in 2017. The market sales performance has grown exponentially and has become an important growth point for the company's.
Ø Drafters of industry standards, the quality is better than similar products;
Ø National medical insurance products, have high pharmacoeconomic value;
Ø Unilateral preparation of precious and rare medicinal materials, the mechanism of action and clinical efficacy are definite, especially in the field of cross-disciplinary diseases, such as coronary heart disease + depression, coronary heart disease + diabetes;
Ø It is extracted from national Chinese medicine plant, no added, safe and no accumulation of toxicity, suitable for long-term chronic disease management in middle-aged and elderly people.